Hemostasis and thrombosis (39)
All Items
-
Eptacog beta for breakthrough elbow hemarthrosis during concizumab prophylaxis in a pediatric patient with hemophilia B: a case report: Episodic eptacog-beta treatment in concizumab prophylaxis
-
Peripartum management of a monochorionic diamniotic twin pregnancy in a woman with mild hemophilia B using eftrenonacog alfa: a case report: A safe delivery in a high-risk setting
-
Homocysteine as a risk factor for thrombosis and when to ask for testing: Homocysteine and thrombosis
-
A case of early pregnancy pulmonary embolism following mifepristone administration: a call for increased pharmacovigilance and research: Early pregnancy pulmonary embolism after mifepristone assumption
-
Frequency of type 2N von Willebrand disease among patients with mild or moderate factor VIII deficiency in an 18-month period in Iran: 2N VWD among mild or moderate FVIII deficient patients in Iran
-
The effective use of platelet-rich plasma (PRP) in treating a severe traumatic knee injury in a child with hemophilia A: PRP in the treatment of severe injury in hemophilia child
-
Rare inherited autosomal bleeding disorders in women: sex-related bleeding, pregnancy and delivery. A narrative review: Autosomal bleeding disorders in women: a narrative review
-
Towards a value-based approach in hemophilia: indications from the FAR-BENE study: Towards a value-based approach in hemophilia
-
Severe hemophilia A with inhibitors and pancreatic cancer – when emicizumab is not enough: Emicizumab isn’t enough
-
Therapeutic plasma exchange-related complications in patients with immune-mediated thrombotic thrombocytopenic purpura: Complications of therapeutic plasma-exchange
-
No bleeding during a dialysis catheter insertion in a patient with INR 3.2 due to acute liver dysfunction: No bleeding during dialysis catheter insertion with INR 3.2
-
FAR-BENE Study: pharmacoeconomics and well-being in hemophilia. Monitoring outcomes in light of pharmaceutical expenditure with focus on patients undergoing therapeutic switch: FAR-BENE Study
-
Turoctocog alfa pegol versus recombinant factor VIII-Fc fusion protein: a head-to-head pharmacokinetics comparison: Turoctocog alfa pegol vs rFVIII‐Fc fusion protein
-
Early fibrinogen replacement based on shock index and lactate levels in massive postpartum hemorrhage: a retrospective cohort study: Early fibrinogen replacement in massive PPH
-
Recommending defunct therapies is a safety risk for hemophilia: Therapies and safety risks in haemophilia
-
Response to comments on inclusion of cryoprecipitate, pathogen-reduced on the WHO model lists of essential medicines for adults and children: a call for action: Responses to comments on Cryo-PR listing on the WHO EML
-
Cryoprecipitate should not be the essential medicine recommended by the WHO to treat haemophilia: Factor VIII concentrate rather than cryoprecipitate for Haemophilia
-
Direct oral anticoagulants measurement: when is it necessary? DOAC measurement
-
Evaluation of platelet function by Total Thrombus-Formation Analysis System (T-TAS®01) in term and preterm infants and its relationship with patent ductus arteriosus. A prospective observational pilot study: T-TAS®01, platelet, and patent ductus arteriosus in newborns
-
Navigating anemia and anticoagulation in elderly patients undergoing orthopedic surgery: strategies for preventing complications and implementing treatments: Anemia and thrombosis in elderly patients undergoing orthopedic surgery
-
Natural history of anti-PF4 antibodies in patients with vaccine-induced immune thrombocytopenia and thrombosis: Anti-PF4 antibodies durability in patients with VITT
-
Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defects: Automated aggregometry for detecting platelet function defects
-
T-TAS® 01 as a new tool for the evaluation of hemostasis in thrombocytopenic patients after platelet transfusion: T-TAS to assess platelet transfusion
-
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology : AIEOP Consensus for childhood acute ITP
-
Global hemostasis assays in acute myeloid leukemia: results of an observational prospective study: Use of TEG in acute myeloid leukemia
39 Items
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more